Podcasts about alcohol use disorder

To kick off Season 4, Charles Marmar, MD, explains how precision psychiatry is reshaping the way clinicians and researchers think about diagnosis, treatment selection, and the underlying biology of psychiatric disorders. This conversation is a overview of where the field stands today—including emerging molecular markers, biologically informed subtypes, and new translational approaches inspired by oncology and other precision-based specialties.Dr. Marmar is Chair of Psychiatry at NYU Grossman School of Medicine, and Director of the Center for the Study of Alcohol Use Disorder and Traumatic Stress.In this episode, he outlines current work on:Molecular and genomic signatures that may distinguish patient subtypesClinical trials examining targeted treatments for alcohol use disorderThe development of proxy “brain biopsy” methods such as exosomal analyses and iPSC-derived organoidsHow converging biological data could eventually support more individualized treatment planningThis discussion reflects ongoing efforts at NYU Langone Health to move psychiatry toward a more mechanism-based, biologically grounded model of care, while acknowledging the complexity and early stage of the work. For clinicians, scientists, and trainees, the episode provides a clear snapshot of the major directions shaping precision psychiatry today.CHAPTERS00:00 Introduction: The Challenge in Psychiatry00:34 Meet the Experts01:07 Understanding PTSD: Types and Subtypes04:47 Current Research and Innovations06:19 The Future of Psychiatry: Precision Medicine09:34 Case Study: Personalized Treatment Success11:33 Conclusion: The Path ForwardVisit our website for more Insights on Psychiatry.Watch this episode on YouTubeExecutive Producer: Jon Earle

For Tom, childhood was filled with positive memories—nothing that hinted he'd ever struggle with alcohol. After college, he stepped into his career, a world where late nights out were normal, and alcohol made social connections feel easier. At first, everything seemed under control. But when the pandemic hit, and isolation became a daily reality, drinking slowly picked up speed. Tom didn't have what many would call a “rock bottom,” but internally, he felt the truth: something had to change. This is Tom's journey of honesty, self-awareness, and choosing a different path.   Check out the Just Between Us Podcast: https://app.helloaudio.fm/feed/07bfba32-e173-41c6-973e-ceee488187c7/signup   00:00 Introduction and Guest Welcome 00:20 Tom's Childhood and Upbringing 01:43 College Life and Fraternity Influence 04:09 Post-College Career and Move to Boston 12:12 Pandemic Impact and Realization 16:42 The Struggle with Alcohol 23:06 The Hidden Truth About Alcohol's Impact on Society 23:55 The Dopamine Connection: Alcohol and Gambling 24:57 Personal Reflections: Evaluating Life Choices 26:05 The Decade Mark: Recognizing the Need for Change 26:50 The Internal Struggle: Awareness and Denial 27:41 The Turning Point: Family and Sobriety 31:20 Navigating Sobriety: Slips and Progress 36:20 Therapy and Support: Tools for Sobriety 40:58 The Journey Continues: Embracing Change 44:45 Final Thoughts: Encouragement and Suppor

Dr. Refky Nicola speaks with Dr. Sudhakar Venkatesh from Mayo Clinic about the imaging manifestations of alcohol use disorder and its widespread impact on the brain, liver, heart, lungs, and musculoskeletal system. The discussion highlights key radiologic findings, from Wernicke's encephalopathy to hepatic fibrosis, and explores how advanced MRI techniques aid in diagnosis and management. Imaging Manifestations of AlcoholUse–associated Disorders and Diseases. Venkatesh et al. RadioGraphics 2025; 45(7):e240189. 

Send us a textIn this episode of WTR Small-Cap Spotlight, Anthony Tennyson, CEO and Co-Founder of Solvonis Therapeutics (LSE: SVNS | OTC: SLVNF), joins host Tim Gerdeman, Vice Chair and Co-Founder of Water Tower Research, and analyst Robert Sassoon to discuss the company's mission to transform care for addiction and mental health disorders.Tennyson shares Solvonis' journey from inception to its Phase 3 lead program for alcohol use disorder (AUD), which achieved 86% patient sobriety in prior Phase 2 trials, and details how the company's **dual R&D strategy—repurposing existing molecules and discovering new small molecules—**has allowed it to progress with exceptional capital efficiency. The discussion also covers the SVN-001 and SVN-002 programs, commercialization strategy, and Solvonis' strong financial position and runway through 2027 as it works toward redefining treatment for one of the world's most pervasive unmet medical needs.

In this minisode, Colleen distills emotional sobriety into its simplest form: learning to recognize when you're operating from your primal state versus your power state. Most of us spend our lives reacting to the world from old programming—patterns shaped by fear, pain, or the need for control—without realizing that we can pause, interrupt, and return to presence. She explains how to move from being controlled by your mind to consciously using it as a tool, how emotional energy drives every “problem,” and how the act of letting go—physically and mentally—is the real path to peace. This is more than nervous system regulation; it's a full reclamation of agency over your inner world.  

In this minisode, Colleen unpacks the hidden link between insecurity and control — and how most of us try to manage our anxiety by managing other people's opinions. Through a grounded, body-based perspective, she reframes confidence not as something you “earn,” but as something you practice by returning to yourself again and again. She challenges the myth that insecurity means something is “wrong” with you. Instead, she explains that it's a call to turn inward — to redirect your energy from controlling perception to cultivating presence. The goal isn't to eliminate self-consciousness, but to move the needle toward self-possession, one thought, one feeling, and one moment at a time.  

What does a healthy relationship with alcohol really look like? Dr. Nzinga Harrison, chief medical officer and co-founder of Eleanor Health, joins Natalie to break down the realities of addiction, substance use disorders, and how compassion and open conversations can transform families. With deep expertise in adult psychiatry and addiction medicine, Dr. Harrison shares actionable tools to recognize early signs, navigate stigma, and support loved ones—plus insights from her new book and experience as a parent. You'll learn how to use the powerful CAGE screening tool, why support systems are essential, and how addiction is influenced by both biology and environment. Discover the importance of self-compassion, how to talk with teens, and the value of the sober curious movement. Whether you're reevaluating your own habits or helping someone else, this episode equips you with practical strategies and hope for lasting wellness. Follow Natalie: Website: https://natalietysdal.com Instagram: https://instagram.com/ntysdal TikTok: https://tiktok.com/@ntysdal Facebook: https://facebook.com/natalietysdal Disclaimer: Natalie Tysdal is a health journalist, not a licensed medical professional. This podcast is informational only, not medical advice.